litlas
Log inCreate account

Ken Yamaguchi

Active 1977–2025

171
Papers
25,666
Citations
91
h-index
160
i10-index

Citations

Citations per year for Ken Yamaguchi1978: 2 citations1979: 2 citations1980: 1 citations1981: 1 citations1983: 1 citations1984: 1 citations1985: 2 citations1986: 1 citations1987: 2 citations1988: 2 citations1989: 2 citations1990: 6 citations1991: 11 citations1992: 11 citations1993: 5 citations1994: 8 citations1995: 7 citations1996: 11 citations1997: 14 citations1998: 17 citations1999: 25 citations2000: 39 citations2001: 41 citations2002: 35 citations2003: 54 citations2004: 57 citations2005: 96 citations2006: 108 citations2007: 118 citations2008: 141 citations2009: 165 citations2010: 182 citations2011: 206 citations2012: 192 citations2013: 218 citations2014: 245 citations2015: 262 citations2016: 259 citations2017: 290 citations2018: 257 citations2019: 910 citations2020: 867 citations2021: 819 citations2022: 624 citations2023: 473 citations2024: 746 citations2025: 312 citations2026: 8 citations1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,599 citing papers, 29.9% of this breakdownChina: 1,394 citing papers, 16.1% of this breakdownJapan: 516 citing papers, 5.9% of this breakdownUnited Kingdom: 387 citing papers, 4.5% of this breakdownItaly: 343 citing papers, 4% of this breakdownGermany: 296 citing papers, 3.4% of this breakdownCanada: 295 citing papers, 3.4% of this breakdownSouth Korea: 278 citing papers, 3.2% of this breakdownFrance: 242 citing papers, 2.8% of this breakdownAustralia: 214 citing papers, 2.5% of this breakdownSpain: 177 citing papers, 2% of this breakdownSwitzerland: 169 citing papers, 1.9% of this breakdown
0%29.9%Other 20.4%

Institutions

Fields

  • Medicine71.4%
  • Biochemistry, Genetics and Molecular Biology15%
  • Immunology and Microbiology9.3%
  • Engineering1.9%
  • Neuroscience1%
  • Computer Science0.3%
  • Other1.1%

Topics

  • Shoulder Injury and Treatment9%
  • Cancer Immunotherapy and Biomarkers8.1%
  • Shoulder and Clavicle Injuries4.9%
  • Immunotherapy and Immune Responses3.8%
  • Immune Cell Function and Interaction3.5%
  • Immune cells in cancer2.7%
  • Other68%

Coauthors

All papers

Open in search
  1. Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

    Authors: Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi - Journal of Clinical Oncology 2015 cited by 1,192

  2. Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition

    Authors: Mana Taki, Kaoru Abiko, Masayo Ukita, Ryusuke Murakami, Koji Yamanoi, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai - Clinical Cancer Research 2021 cited by 360

  3. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

    Authors: Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Naoki Horikawa, Ryusuke Murakami, Ken Yamaguchi, Yumiko Yoshioka, Tsukasa Baba, Ikuo Konishi, Masaki Mandai - British Journal of Cancer 2015 cited by 709

  4. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer

    Authors: Masayo Ukita, Junzo Hamanishi, Hiroyuki Yoshitomi, Koji Yamanoi, Shiro Takamatsu, Akihiko Ueda, Haruka Suzuki, Yuko Hosoe, Yoko Furutake, Mana Taki, Kaoru Abiko, Ken Yamaguchi, Hidekatsu Nakai, Tsukasa Baba, Noriomi Matsumura, Akihiko Yoshizawa, Hideki Ueno, Masaki Mandai - JCI Insight 2022 cited by 190

  5. The Outcome and Repair Integrity of Completely Arthroscopically Repaired Large and Massive Rotator Cuff Tears

    Authors: Leesa M. Galatz, Craig M. Ball, Sharlene A. Teefey, William D. Middleton, Ken Yamaguchi - Journal of Bone and Joint Surgery 2004 cited by 2,146

  6. B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression

    Authors: Taito Miyamoto, Ryusuke Murakami, Junzo Hamanishi, Kenji Tanigaki, Yuko Hosoe, Nathan Mise, Shiro Takamatsu, Yuka Mise, Masayo Ukita, Mana Taki, Koji Yamanoi, Naoki Horikawa, Kaoru Abiko, Ken Yamaguchi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai - Cancer Immunology Research 2021 cited by 153

  7. Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

    Authors: Peng Jin, Junzo Hamanishi, Noriomi Matsumura, Kaoru Abiko, Kumuruz Murat, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Yuko Hosoe, Susan K. Murphy, Ikuo Konishi, Masaki Mandai - Cancer Research 2015 cited by 522

  8. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer

    Authors: Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki, Taku Okazaki, Yoshimasa Tanaka, Ken Yamaguchi, Toshihiro Higuchi, Haruhiko Yagi, Kenji Takakura, Nagahiro Minato, Tasuku Honjo, Shingo Fujii - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 1,372

  9. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells

    Authors: Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Tsukasa Baba, Ken Yamaguchi, Yumiko Yoshioka, Masafumi Koshiyama, Ikuo Konishi - Clinical Cancer Research 2016 cited by 280

  10. VISTA expressed in tumour cells regulates T cell function

    Authors: Kumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, Kenji Chamoto, Nathan Mise, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Ryusuke Murakami, Mana Taki, Budiman Kharma, Xiang Zeng, Yuko Hosoe, Miyuki Azuma, Ikuo Konishi, Masaki Mandai - British Journal of Cancer 2018 cited by 205

  11. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation

    Authors: Mana Taki, Kaoru Abiko, Tsukasa Baba, Junzo Hamanishi, Ken Yamaguchi, Ryusuke Murakami, Koji Yamanoi, Naoki Horikawa, Yuko Hosoe, Eijiro Nakamura, Aiko Sugiyama, Masaki Mandai, Ikuo Konishi, Noriomi Matsumura - Nature Communications 2018 cited by 309

  12. THE DEMOGRAPHIC AND MORPHOLOGICAL FEATURES OF ROTATOR CUFF DISEASE

    Authors: Ken Yamaguchi, Κωνσταντίνος Δίτσιος, William D. Middleton, Charles F. Hildebolt, Leesa M. Galatz, Sharlene A. Teefey - Journal of Bone and Joint Surgery 2006 cited by 902

  13. Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress

    Authors: Ken Yamaguchi, Masaki Mandai, Shinya Toyokuni, Junzo Hamanishi, Toshihiro Higuchi, Kenji Takakura, Shingo Fujii - Clinical Cancer Research 2008 cited by 322

  14. A T-cell–engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer

    Authors: Akira Iizuka, Chizu Nonomura, Tadashi Ashizawa, Ryota Kondou, Keiichi Ohshima, Takashi Sugino, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Kouji Maruyama, Ken Yamaguchi, Yasuto Akiyama - Clinical Cancer Research 2019 cited by 76

  15. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer

    Authors: Meng Qin, Junzo Hamanishi, Masayo Ukita, Koji Yamanoi, Shiro Takamatsu, Kaoru Abiko, Ryusuke Murakami, Taito Miyamoto, Haruka Suzuki, Akihiko Ueda, Yuko Hosoe, Akihito Horie, Ken Yamaguchi, Masaki Mandai - Cancer Immunology Immunotherapy 2021 cited by 48

  16. Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment

    Authors: Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Tsukasa Baba, Junzo Hamanishi, Ken Yamaguchi, Ryusuke Murakami, Mana Taki, Masayo Ukita, Yuko Hosoe, Masafumi Koshiyama, Ikuo Konishi, Masaki Mandai - British Journal of Cancer 2020 cited by 91

  17. Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line

    Authors: Keiichi Ohshima, Kanako Inoue, A Fujiwara, Keiichi Hatakeyama, Kaori Kanto, Yuko Watanabe, Koji Muramatsu, Yorikane Fukuda, Shun‐ichiro Ogura, Ken Yamaguchi, Tohru Mochizuki - PLoS ONE 2010 cited by 578

  18. PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction

    Authors: Kaoru Abiko, Masaki Mandai, Junzo Hamanishi, Yumiko Yoshioka, Noriomi Matsumura, Tsukasa Baba, Ken Yamaguchi, Ryusuke Murakami, Ayaka Yamamoto, Budiman Kharma, Kenzo Kosaka, Ikuo Konishi - Clinical Cancer Research 2013 cited by 233

  19. Natural history of asymptomatic rotator cuff tears: A longitudinal analysis of asymptomatic tears detected sonographically

    Authors: Ken Yamaguchi, A. Marc Tetro, Oren Blam, Bradley Evanoff, Sharlene A. Teefey, William D. Middleton - Journal of Shoulder and Elbow Surgery 2001 cited by 637

  20. A Prospective Evaluation of Survivorship of Asymptomatic Degenerative Rotator Cuff Tears

    Authors: Jay D. Keener, Leesa M. Galatz, Sharlene A. Teefey, William D. Middleton, Karen Steger-May, Georgia Stobbs-Cucchi, Rebecca Patton, Ken Yamaguchi - Journal of Bone and Joint Surgery 2015 cited by 237

  21. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

    Authors: Kui Li, Masaki Mandai, Junzo Hamanishi, Noriomi Matsumura, Ayako Suzuki, Haruhiko Yagi, Ken Yamaguchi, Tsukasa Baba, Shingo Fujii, Ikuo Konishi - Cancer Immunology Immunotherapy 2008 cited by 174

  22. Symptomatic Progression of Asymptomatic Rotator Cuff Tears

    Authors: Nathan A. Mall, H. Mike Kim, Jay D. Keener, Karen Steger-May, Sharlene A. Teefey, William D. Middleton, Georgia Stobbs, Ken Yamaguchi - Journal of Bone and Joint Surgery 2010 cited by 363

  23. Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks

    Authors: Ryusuke Murakami, Noriomi Matsumura, J.B. Brown, Koichiro Higasa, Takanobu Tsutsumi, Mayumi Kamada, Hisham Abou-Taleb, Yuko Hosoe, Sachiko Kitamura, Ken Yamaguchi, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masafumi Koshiyama, Yasushi Okuno, Ryo Yamada, Fumihiko Matsuda, Ikuo Konishi, Masaki Mandai - American Journal Of Pathology 2017 cited by 137

  24. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types

    Authors: Shiro Takamatsu, J. Brown, Ken Yamaguchi, Junzo Hamanishi, Koji Yamanoi, Hisamitsu Takaya, Tomoko Kaneyasu, Seiichi Mori, Masaki Mandai, Noriomi Matsumura - JCO Precision Oncology 2022 cited by 48